As a subsequent outcome, the improved fatty acid metabolism in liver with Met supplementation reduces the risk of liver dysfunction, an idea supported by the biomarkers of liver function (e.g. greater albumin and VLDL, and lower bilirubin) in OVE + SM cows [47]. The gene discussed is ALB; the disease is Decreased liver function.